Single-group Phase I dose-ranging study (n=14) characterising subjective and behavioural effects of salvinorin A in healthy volunteers, administered via inhalation.
Single‑group, triple‑masked, Phase I study in healthy volunteers assessing the subjective and behavioural effects of salvinorin A in an initial dose‑ranging protocol.
Participants must have prior inhalation use of Salvia/salvinorin A; sessions involve single inhaled administrations with dose escalation guided by safety assessments.
Outcomes focus on acute subjective effects, behavioural measures, and safety/tolerability through physiological monitoring and laboratory tests.
Initial dose‑ranging, single‑group study of salvinorin A in healthy volunteers.
Salvinorin A — initial dose‑ranging; drug administered via inhalation (dose escalation per protocol).